研究者詳細 - 野間　和広

MISC - 野間　和広

分割表示 1,077 件中 401 - 420 件目／全件表示 >>

食道癌周術期管理におけるエビデンス創出に向けたPERiOの現況と課題

白川靖博, 橋本将志, 小林照貴, 前田直見, 田辺俊介, 櫻間教文, 野間和広, 西崎正彦, 藤原俊義

日本食道学会学術集会抄録集(CD-ROM) 73rd 2019年

食道切除における血流評価を元に行う安全な胃管・空腸再建法

野間和広, 橋本将志, 小林照貴, 前田直見, 田辺俊介, 櫻間教文, 西崎正彦, 藤原俊義

日本食道学会学術集会抄録集(CD-ROM) 73rd 2019年

食道胃接合部癌168例の治療経験から導かれる最適な集学的治療

野間和広, 白川靖博, 西脇紀之, 松田達雄, 前田直見, 田辺俊介, 西崎正彦, 香川俊輔, 藤原俊義

日本外科学会定期学術集会(Web) 119th 2019年

食道癌術後再発に対する手術療法の意義の検討

前田直見, 白川靖博, 橋本将志, 小林照貴, 田辺俊介, 櫻間教文, 野間和広, 西崎正彦, 藤原俊義

日本食道学会学術集会抄録集(CD-ROM) 73rd 2019年

ゼロ価鉄ナノ粒子を用いた油性溶媒中PCBの脱塩素分解技術の開発

野間淳一, 高木和広, 栢岡理

廃棄物資源循環学会研究発表会講演集(Web) 30th 2019年

Dual-targeting Photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in tumor microenvironment

Hiroaki Sato, Kazuhiro Noma, Toru Narusaka, Satoshi Komoto, Toshiaki Ohara, Hiroshi Tazawa, Toshiyoshi Fujiwara

CANCER SCIENCE 109 371 - 371 2018年12月

Visualization of epithelial-mesenchymal transition in inflammatory microenvironment-colorectal cancer crosstalk

Hiroshi Tazawa, Takeshi Ieda, Shuya Yano, Kunitoshi Shigeyasu, Shinji Kuroda, Toshiaki Ohara, Kazuhiro Noma, Hiroyuki Kishimoto, Masahiko Nishizaki, Shunsuke Kagawa, Takashi Saitou, Takeshi Imamura, Toshiyoshi Fujiwara

CANCER SCIENCE 109 669 - 669 2018年12月

Stemness control by iron chelator is a novel strategy for cancer treatment

Toshiaki Ohara, Yuki Katsura, Kazuhiro Noma, Toru Narusaka, Hiroaki Sato, Satoshi Komoto, Takuya Kato, Hiroshi Tazawa, Shunsuke Kagawa, Toshiyoshi Fujiwara

CANCER SCIENCE 109 1309 - 1309 2018年12月

Near-infrared photoimmunotherapy using anti-GD2 antibody-photosensitizer conjugate for neuroblastoma

Hiroshi Nouso, Hiroshi Tazawa, Terutaka Tanimoto, Morimochi Tani, Takanori Oyama, Hiroaki Sato, Kazuhiro Noma, Shunsuke Kagawa, Hisataka Kobayashi, Takuo Noda, Toshiyoshi Fujiwara

CANCER SCIENCE 109 1140 - 1140 2018年12月

Novel virotherapy for scirrhous gastric cancer with peritoneal metastasis

Wataru Ishikawa, Satoru Kikuchi, Hiroshi Tazawa, Shinji Kuroda, Kazuhiro Noma, Hiroyuki Kishimoto, Masahiko Nishizaki, Yasuo Urata, Shunsuke Kagawa, Toshiyoshi Fujiwara

CANCER SCIENCE 109 761 - 761 2018年12月

Cancer-associated fibroblasts affect the intra-tumoral infiltration of CD8+and FoxP3+T cells via IL-6

Takuya Kato, Kazuhiro Noma, Hiroaki Sato, Satoshi Komoto, Toshiaki Ohara, Hiroshi Tazawa, Yasuhiro Shirakawa, Toshiyoshi Fujiwara

CANCER SCIENCE 109 1120 - 1120 2018年12月

Oncolytic virotherapy for inhibition of epithelial- mesenchymal transition in esophageal cancer

Tomoya Masuda, Hiroshi Tazawa, Takeshi Ieda, Yuuri Hashimoto, Shunsuke Tanabe, Kazuhiro Noma, Yasuo Urata, Shunsuke Kagawa, Yasuhiro Shirakawa, Toshiyoshi Fujiwara

CANCER SCIENCE 109 868 - 868 2018年12月

Cancer-Associated Fibroblasts Affect Intratumoral CD8(+) and FoxP3(+) T Cells Via IL6 in the Tumor Microenvironment 査読国際誌

Kato Takuya, Noma Kazuhiro, Ohara Toshiaki, Kashima Hajime, Katsura Yuki, Sato Hiroaki, Komoto Satoshi, Katsube Ryoichi, Ninomiya Takayuki, Tazawa Hiroshi, Shirakawa Yasuhiro, Fujiwara Toshiyoshi

CLINICAL CANCER RESEARCH 24 ( 19 ) 4820 - 4833 2018年10月

癌関連線維芽細胞が放出するIL-6が腫瘍内に浸潤するCD8+ならびにFoxP3+T細胞に影響を与える(Cancer-associated fibroblasts affect the intra-tumoral infiltration of CD8+ and FoxP3+ T cells via IL-6)

加藤卓也, 野間和広, 佐藤浩明, 河本慧, 大原利章, 田澤大, 白川靖博, 藤原俊義

日本癌学会総会記事 77回 1860 - 1860 2018年9月

消化管がん治療の新展開食道癌におけるがん細胞及びがん関連線維芽細胞に対するDual-targeting Photoimmunotherapy(Developments in gastrointestinal cancer treatments Dual-targeting Photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in tumor microenvironment) 査読

佐藤浩明, 野間和広, 鳴坂徹, 河本慧, 大原利章, 田澤大, 藤原俊義

日本癌学会総会記事 77回 96 - 96 2018年9月

炎症性微小環境-大腸がんクロストークにおけるEMTイメージング(Visualization of epithelial-mesenchymal transition in inflammatory microenvironment-colorectal cancer crosstalk) 査読

田澤大, 家田偉史, 矢野修也, 重安邦俊, 黒田新士, 大原利章, 野間和広, 岸本浩行, 西崎正彦, 香川俊輔, 斎藤卓, 今村健志, 藤原俊義

日本癌学会総会記事 77回 1204 - 1204 2018年9月

鉄キレート剤の幹細胞性制御による新規癌治療法(Stemness control by iron chelator is a novel strategy for cancer treatment) 査読

大原利章, 桂佑貴, 野間和広, 鳴坂徹, 佐藤浩明, 河本慧, 加藤卓也, 田澤大, 香川俊輔, 藤原俊義

日本癌学会総会記事 77回 2318 - 2318 2018年9月

腹膜播種を伴うスキルス胃癌に対する斬新なウイルス療法(Novel virotherapy for scirrhous gastric cancer with peritoneal metastasis)

石川亘, 菊地覚次, 田澤大, 黒田新士, 野間和広, 岸本浩行, 西崎正彦, 浦田泰生, 香川俊輔, 藤原俊義

日本癌学会総会記事 77回 952 - 952 2018年9月

神経芽腫に対する抗GD2抗体-光感受性物質結合体を用いた光線免疫療法(Near-infrared photoimmunotherapy using anti-GD2 antibody-photosensitizer conjugate for neuroblastoma)

納所洋, 田澤大, 谷本光隆, 谷守通, 尾山貴徳, 佐藤浩明, 野間和広, 香川俊輔, 小林久隆, 野田卓男, 藤原俊義

日本癌学会総会記事 77回 1948 - 1948 2018年9月

Clinical characteristics and management of gastric tube cancer after esophagectomy 査読

Yasuhiro Shirakawa, Kazuhiro Noma, Naoaki Maeda, Takayuki Ninomiya, Shunsuke Tanabe, Satoru Kikuchi, Shinji Kuroda, Masahiko Nishizaki, Shunsuke Kagawa, Yoshiro Kawahara, Hiroyuki Okada, Toshiyoshi Fujiwara

Esophagus 15 ( 3 ) 180 - 189 2018年7月

記述言語：英語出版者・発行元：Springer Tokyo

Background: Gastric cancer is the second most common malignancy, overlapping with thoracic esophageal cancer (TEC). Among them, metachronous gastric tube cancers after TEC surgery have been increasing. The aims of this study were to examine the clinicopathological factors and treatment outcomes of gastric tube cancer (GTC) after TEC surgery. Methods: Thirty-three GTCs in 30 cases after TEC treated between 1997 and 2016 were investigated retrospectively. Results: Most cases were males. The median interval from TEC surgery to GTC occurrence was 57 (6.5–107.5) months. Almost 2/3 lesions occurred in the lower third of the gastric tube (21/33)
29 lesions (in 26 cases) were superficial cancers, and 4 lesions were advanced cancers. Twenty-two lesions of superficial cancer were differentiated type, and the remaining seven lesions were undifferentiated type. Treatment for superficial cancer had previously been performed with partial gastric tube resection (10 lesions), and the number of cases undergoing endoscopic submucosal dissection (ESD) had increased recently (19 lesions). Most cases with superficial cancer survived without relapse. Four lesions of advanced cancer were found after a relatively long interval following TEC surgery. Most lesions of advanced cancer were scirrhous, undifferentiated type, and they died due to GTC. Conclusion: GTCs may occur late in the postoperative course following TEC surgery. If they are discovered at an early stage, these lesions can be cured with ESD. Long-term periodic endoscopic examinations after TEC surgery are important.

DOI： 10.1007/s10388-018-0611-2

<野間 和広>

MISC - 野間 和広

<野間　和広>

MISC - 野間　和広